Literature DB >> 25907334

Future treatment of gonorrhea--novel emerging drugs are essential and in progress?

Magnus Unemo1, William M Shafer.   

Abstract

Entities:  

Keywords:  Neisseria gonorrhoeae; gonorrhoea; resistance; treatment

Mesh：

Substances：

Year:  2015        PMID： 25907334      PMCID： PMC4550495          DOI： 10.1517/14728214.2015.1039981

Source DB:  PubMed          Journal:  Expert Opin Emerg Drugs        ISSN： 1472-8214            Impact factor:   4.191


× No keyword cloud information.
  14 in total

1.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

Review 2.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Antibiotic-resistant strains of Neisseria gonorrhoeae. Policy guidelines for detection, management, and control.

Authors: 
Journal:  MMWR Suppl       Date:  1987-09-11

Review 4.  Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.

Authors:  Namraj Goire; Monica M Lahra; Marcus Chen; Basil Donovan; Christopher K Fairley; Rebecca Guy; John Kaldor; David Regan; James Ward; Michael D Nissen; Theo P Sloots; David M Whiley
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

5.  High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.

Authors:  Susanne Jacobsson; Daniel Golparian; Richard A Alm; Michael Huband; John Mueller; Jorgen Skov Jensen; Makoto Ohnishi; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 6.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

7.  In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?

Authors:  Daniel Golparian; Prabhavathi Fernandes; Makoto Ohnishi; Jörgen S Jensen; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

Review 8.  Current and future treatment options for gonorrhoea.

Authors:  Catherine A Ison; Carolyn Deal; Magnus Unemo
Journal:  Sex Transm Infect       Date:  2013-10-08       Impact factor: 3.519

9.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

Authors:  C Bignell; M Unemo
Journal:  Int J STD AIDS       Date:  2013-02       Impact factor: 1.359

10.  Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.

Authors:  Kakoli Roy; Susan A Wang; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883
View more
  6 in total

1.  Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil.

Authors:  Ana Paula Ramalho Costa-Lourenço; Jeanine A Abrams; Késia Thaís Barros Dos Santos; Talita Coelho-Souza; Beatriz Meurer Moreira; Sergio Eduardo Longo Fracalanzza; David L Trees; Raquel Regina Bonelli
Journal:  Int J Antimicrob Agents       Date:  2017-02-21       Impact factor: 5.283

2.  Identification and Characterization of the Neisseria gonorrhoeae MscS-Like Mechanosensitive Channel.

Authors:  Zhemin Wang; Xiaomin Wang; Ping Lu; Chunshan Ni; Yuezhou Li; Stijn van der Veen
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

Review 3.  Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.

Authors:  Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

Review 4.  Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.

Authors:  Ana Paula Ramalho da Costa-Lourenço; Késia Thaís Barros Dos Santos; Beatriz Meurer Moreira; Sergio Eduardo Longo Fracalanzza; Raquel Regina Bonelli
Journal:  Braz J Microbiol       Date:  2017-07-12       Impact factor: 2.476

Review 5.  Gonorrhea - an evolving disease of the new millennium.

Authors:  Stuart A Hill; Thao L Masters; Jenny Wachter
Journal:  Microb Cell       Date:  2016-09-05

6.  The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.

Authors:  Isabelle Leduc; Kristie L Connolly; Afrin Begum; Knashka Underwood; Stephen Darnell; William M Shafer; Jacqueline T Balthazar; Andrew N Macintyre; Gregory D Sempowski; Joseph A Duncan; Marguerite B Little; Nazia Rahman; Eric C Garges; Ann E Jerse
Journal:  PLoS Pathog       Date:  2020-12-08       Impact factor: 6.823
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.